Cargando…
AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation
Despite being the frontline therapy for type 2 diabetes, the mechanisms of action of the biguanide drug metformin are still being discovered. In particular, the detailed molecular interplays between the AMPK and the mTORC1 pathway in the hepatic benefits of metformin are still ill defined. Metformin...
Autores principales: | Van Nostrand, Jeanine L., Hellberg, Kristina, Luo, En-Ching, Van Nostrand, Eric L., Dayn, Alina, Yu, Jingting, Shokhirev, Maxim N., Dayn, Yelena, Yeo, Gene W., Shaw, Reuben J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528705/ https://www.ncbi.nlm.nih.gov/pubmed/32912901 http://dx.doi.org/10.1101/gad.339895.120 |
Ejemplares similares
-
AMPK governs lineage specification through Tfeb-dependent regulation of lysosomes
por: Young, Nathan P., et al.
Publicado: (2016) -
AMPK/ULK1-mediated phosphorylation of Parkin ACT domain mediates an early step in mitophagy
por: Hung, Chien-Min, et al.
Publicado: (2021) -
Therapeutic Trial of Metformin and Bortezomib in a Mouse Model of Tuberous Sclerosis Complex (TSC)
por: Auricchio, Neil, et al.
Publicado: (2012) -
Metformin effectively treats Tsc1 deletion-caused kidney pathology by upregulating AMPK phosphorylation
por: Fang, Yili, et al.
Publicado: (2020) -
Discovery and Analysis of Evolutionarily Conserved Intronic Splicing Regulatory Elements
por: Yeo, Gene W, et al.
Publicado: (2007)